Rohit Vishnoi is Director at Insys Therapeutics, Inc. (INSY). They have made 1 open-market trade across 1 company since 2017, most recently 2019-03-04.
CIK 0001706245
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $57K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INSY | 16,000 | $5K |
Shares reported on the most recent Form 4, priced at the 2019-04-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INSY | BUY | 2017-06-01 | 2017-06-02 | $14.14 | $57K | -13.8% | -3.3% | -30.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.